USANA Health Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Net Income	42.03	63.79	69.35	116.51
Depreciation & Amortization	22.23	20.4	21.41	22.19
Loss (Gain) From Sale of Assets	0	0.01	0.14	0.06
Stock-Based Compensation	14.56	14.6	13.33	14.3
Other Operating Activities	-4.82	-0.15	-1.1	1.23
Change in Inventory	-2.12	2.35	15.8	-14.7
Change in Accounts Payable	-1.27	-0.43	-2.66	-4.57
Change in Other Net Operating Assets	-9.62	-29.92	-12.37	-13.79
Operating Cash Flow	60.99	70.64	103.9	121.23
Operating Cash Flow Growth	-13.66%	-32.01%	-14.29%	-24.42%
Capital Expenditures	-10.07	-14.49	-10.4	-12.76
Sale of Property, Plant & Equipment	0.06	0.02	0.01	0.02
Cash Acquisitions	-203.34	-	-6.53	-
Other Investing Activities	0.26	2.5	4.56	-1.44
Investing Cash Flow	-213.09	-11.98	-12.37	-14.19
Short-Term Debt Issued	23.69	1.54	11	-
Total Debt Issued	23.69	1.54	11	-
Short-Term Debt Repaid	-1.47	-0.75	-11	-
Total Debt Repaid	-1.47	-0.75	-11	-
Net Debt Issued (Repaid)	22.22	0.79	-	-
Repurchase of Common Stock	-12.67	-14.69	-30.09	-181.41
Other Financing Activities	-	-0.34	-	-
Financing Cash Flow	9.55	-14.24	-30.09	-181.41
Foreign Exchange Rate Adjustments	-6.19	-2.5	-13.78	2.09
Net Cash Flow	-148.74	41.93	47.67	-72.28
Free Cash Flow	50.92	56.15	93.5	108.46
Free Cash Flow Growth	-9.31%	-39.95%	-13.79%	-25.36%
Free Cash Flow Margin	5.96%	6.10%	9.36%	9.14%
Free Cash Flow Per Share	2.66	2.90	4.84	5.33
Cash Interest Paid	0.08	0.07	0.05	0.01
Cash Income Tax Paid	40.4	42.33	45.75	59.33
Levered Free Cash Flow	57.95	61.35	104.19	112.81
Unlevered Free Cash Flow	58.13	61.51	104.31	112.84
Change in Working Capital	-13	-28	0.77	-33.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.